6616 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Clinical Oncology Study Section. 

Date: February 28–March 1, 2022. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Laura Asnaghi, Ph.D., 

Scientific Review Officer, National Institute 

of Health, Center for Scientific Review, 6701 

Rockville Drive, Room 6200, MSC 7804, 

Bethesda, MD 20892, (301) 443–1196, 

laura.asnaghi@nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Healthcare and Health Disparities Study 

Section. 

Date: March 3–4, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jessica Bellinger, Ph.D., 

Scientific Review Officer, Center for 

Scientific of Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

Bethesda, MD 20892, 301–827–4446, 

bellingerjd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Risks, Prevention and Health 

Behavior. 

Date: March 3–4, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Martha M. Faraday, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

3575, faradaym@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Lifestyle Change and Behavioral Health 

Study Section. 

Date: March 3–4, 2022. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pamela Jeter, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 10J08, 

Bethesda, MD 20892, (301) 827–6401, 

pamela.jeter@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR21–326: 

Modern Equipment for Shared-Use 

Biomedical Research Facilities: Advancing 

Research-Related Operations. 

Date: March 3–4, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jonathan Michael 

Peterson, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 867–5309, 

jonathan.peterson@nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Cellular Signaling 

and Regulatory Systems Study Section. 

Date: March 3–4, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David Balasundaram, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5189, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1022, balasundaramd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Motivated Behavior, Alcohol and 

Neurotoxicology. 

Date: March 9, 2022. 

Time: 11:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Michael Selmanoff, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5164, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1119, selmanom@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Pain, Chemosensation and Sensory 

Motor Neurobiology. 

Date: March 10, 2022. 

Time: 10:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Roger Janz, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–8515, janzr2@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group; 

HIV Molecular Virology, Cell Biology, and 

Drug Development Study Section. 

Date: March 14–15, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kenneth A. Roebuck, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5214, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1166, roebuckk@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology B Integrated Review Group; 

HIV Comorbidities and Clinical Studies 

Study Section. 

Date: March 15–16, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David C. Chang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 451–0290, changdac@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 31, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02330 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Initial Review 

Group Genome Research Study Section. 

Date: March 3, 2022. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6617 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Suite 3100, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Keith McKenney, Ph.D, 

Scientific Review Officer, National Human 

Genome Research Institute, National 

Institutes of Health, 6700B Rockledge Drive, 

Suite 3100, Bethesda, MD 20817, 301–594– 

4280, mckenneyk@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: January 31, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02331 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Centers for HIV Structural 

Biology (U54 Clinical Trial Not Allowed). 

Date: March 2–3, 2022. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: J. Bruce Sundstrom, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11A, 

Rockville, MD 20892, 240–669–5045, 

sundstromj@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 31, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02346 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

The meeting will be held virtually 

and is open to the public. Individuals 

who plan to view the virtual meeting 

and need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting will be videocast 

and can be accessed from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov). 

Name of Committee: Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

Date: February 24, 2022. 

Time: 1:00 p.m. to 4:30 p.m. 

Agenda: Ongoing and new activities at the 

Frederick National Laboratory for Cancer 

Research. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Contact Person: Wlodek Lopaczynski, 

M.D., Ph.D., Assistant Director, Office of the 

Director, Division of Extramural Activities, 

National Cancer Institute, National Institutes 

of Health, 9609 Medical Center Drive, 

Seventh Floor, West Tower, Room 7W514, 

Bethesda, MD 20892, (240) 276–6458, 

lopacw@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: FNLAC: 

https://deainfo.nci.nih.gov/advisory/fac/ 

fac.htm, where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 1, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02367 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute on 

Aging Special Emphasis Panel, March 

23, 2022, 11:30 a.m. to March 23, 2022, 

02:30 p.m., National Institute on Aging, 

Gateway Building, 7201 Wisconsin 

Avenue, Bethesda, MD 20892, which 

was published in the Federal Register 

on December 28, 2021, FR Doc. 2021– 

28091, 86 FR 73792. 

The meeting notice is amended to 

change the Contact Person from: Anita 

H. Undale, MD, Ph.D., Scientific Review 

Officer, Scientific Review Branch, 

National Institute on Aging, National 

Institutes of Health, Gateway Building, 

Suite 2W200, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, 301–827–7428, 

anita.undale@nih.gov to Bita Nakhai, 

Ph.D., Scientific Review Officer, 

Scientific Review Branch, National 

Institute on Aging, National Institutes of 

Health, Gateway Bldg., 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 

20892, 301–402–7701, nakhaib@

nia.nih.gov. The meeting is closed to the 

public. The meeting is closed to the 

public. 

Dated: January 31, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02334 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 


lotter on DSK11XQN23PROD with NOTICES1